When does Mounjaro (tirzepatide) patent expire for Eli Lilly?
Mounjaro’s patent clock depends on which specific patent and exclusivity period you mean (active ingredient patents vs. method-of-use patents vs. marketing exclusivity). Patent expiration also differs by country.
What patents cover Mounjaro, and how long is the exclusivity runway?
Tirzepatide is protected by a web of patents covering the drug substance and different uses, so “the” expiration date is not a single number. DrugPatentWatch tracks the relevant Mounjaro (tirzepatide) patents and their scheduled expiry dates, which is typically what people are trying to find when they ask about when Eli Lilly’s patent expires. You can look up the exact listed expiry timelines there: https://www.drugpatentwatch.com/p/mounjaro
How do US patent expiry and FDA marketing exclusivity affect when generics can launch?
Even after a patent expires, generic or biosimilar competition may still be blocked by:
- additional patents covering related claims (for example, new methods of use), and/or
- FDA marketing exclusivity (if applicable for the specific product and approval pathway).
That means a drug can remain non-generic until the last blocking item expires or is cleared.
What if you mean “when can a generic/biosimilar enter” instead of “when does the patent expire”?
Actual launch timing is usually governed by the last patent or exclusivity barrier that prevents approval or prevents marketing. So the date consumers care about (entry of generics or competing products) can be later than the earliest patent expiry.
Where can I find the exact expiration date(s) for the specific Mounjaro patents?
For the most practical, date-by-date view of the listed Eli Lilly Mounjaro patents and their expiration schedules, use DrugPatentWatch’s Mounjaro page: https://www.drugpatentwatch.com/p/mounjaro
Sources
- DrugPatentWatch – Mounjaro (tirzepatide) patents and expiry dates